Patent Number: 8,586,024

Title: Long lasting drug formulations

Abstract: The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a vector which comprises a nucleic acid sequence operably linked to one or more regulatory sequences, wherein the nucleic acid sequence encodes a therapeutic polypeptide, such as erythropoietin or interferon alpha.

Inventors: Pearlman; Andrew L. (D.N. Misgav, IL), Stern; Baruch S. (Haifa, IL)

Assignee: Medgenics Medical Israel Ltd.

International Classification: A01N 63/00 (20060101)

Expiration Date: 1/19/12018